TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22077482

Group type: EXPERIMENTAL
Intervention: 40 mg oral phytoestrogen (Promensil)/day
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: 80 mg oral phytoestrogen (Promensil)/day
Number of subjects: 43

Group type: COMPARATOR
Intervention: 0.05 mg transdermal oestrogen/day
Number of subjects: 43

Group type: COMPARATOR
Intervention: 0.1 mg transdermal oestrogen/day
Number of subjects: 43
Study: 20427397

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: COX-2 expression
Number of subjects: 136
Study: 18020844

Group type: EXPERIMENTAL
Intervention: Human advice
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Automated advice
Number of subjects: 218

Group type: COMPARATOR
Intervention: Health education control
Number of subjects: 218
Study: 16258776

Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (DES)
Number of subjects: 62
Study: 12384804

Group type: EXPERIMENTAL
Intervention: autologous TIL plus interleukin‐2 (IL‐2)
Number of subjects: 88

Group type: COMPARATOR
Intervention: IL‐2 only
Number of subjects: 88
Study: 10570677

Group type: EXPERIMENTAL
Intervention: Reduced-fat diet
Number of subjects: 110

Group type: COMPARATOR
Intervention: Usual diet
Number of subjects: 110
Study: 7624601

Group type: EXPERIMENTAL
Intervention: Combined astemizole, 20 mg, and ranitidine, 600 mg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 2655611

Group type: EXPERIMENTAL
Intervention: Cicletanine 50 mg/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cicletanine 100 mg/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cicletanine 200 mg/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cicletanine 50 mg/d and 100 mg/d
Number of subjects: 0
Study: 1252849

Group type: EXPERIMENTAL
Intervention: Ultrasonic Doppler angiography
Number of subjects: 40

Group type: COMPARATOR
Intervention: Venography
Number of subjects: 40
Study: 31025253

Group type: EXPERIMENTAL
Intervention: Self-help Cognitive Behavioral Therapy (CBT) workbook
Number of subjects: 140

Group type: COMPARATOR
Intervention: Active psychoeducational control workbook
Number of subjects: 140
Study: 30850240

Group type: EXPERIMENTAL
Intervention: HBsAg‐AS01B
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: HBsAg‐Alum
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 27395069

Group type: EXPERIMENTAL
Intervention: Myringotomy with transtympanic short-term tube insertion; tube in tympanic membrane for less than 12 months
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Myringotomy with transtympanic short-term tube insertion; incision in anterior-inferior quadrant
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Myringotomy with transtympanic short-term tube insertion; greater number of otitis episodes
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Myringotomy with transtympanic short-term tube insertion; greater number of otorrhea episodes
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Myringotomy with transtympanic short-term tube insertion; tympanogram type A after tube extraction
Number of subjects: 156
Study: 25972136

Group type: EXPERIMENTAL
Intervention: Micronized purified flavonoid fraction (MPFF; Daflon® 500 mg)
Number of subjects: 592

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 592
Study: 23857160

Group type: EXPERIMENTAL
Intervention: General anaesthesia
Number of subjects: 51

Group type: COMPARATOR
Intervention: Combined spinal epidural anaesthesia
Number of subjects: 51
Study: 22043671

Group type: EXPERIMENTAL
Intervention: Acupuncture program with points in the neck, points in the glossopharyngeal part, and points selected according to syndrome differentiation, deep puncture, for 6 sessions
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Acupuncture program with points in the neck, points in the glossopharyngeal part, and points selected according to syndrome differentiation, deep puncture, for 4 sessions
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Deep puncture (C3)
Number of subjects: 63
Study: 19481327

Group type: EXPERIMENTAL
Intervention: Microwave irradiation for 3 min (650W)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Microwave irradiation for 2 min (650W)
Number of subjects: 30
Study: 16566626

Group type: EXPERIMENTAL
Intervention: Paroxetine (N=13)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Desipramine (N=11)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo (N=11)
Number of subjects: 35
Study: 12687289

Group type: EXPERIMENTAL
Intervention: TJ-14 (7.5 g/day)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study: 10980100

Group type: EXPERIMENTAL
Intervention: Pressure Control Ventilation (PCV)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Volume Control Ventilation (VCV)
Number of subjects: 18
Study: 9378835

Group type: EXPERIMENTAL
Intervention: Essential oil mouthrinse
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Triclosan mouthrinse
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo control for essential oil mouthrinse
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo control for triclosan mouthrinse
Number of subjects: 32
Study: 8335984

Group type: EXPERIMENTAL
Intervention: Cold-adapted reassortant influenza B/Yamagata/10/88 virus vaccine
Number of subjects: 14

Group type: COMPARATOR
Intervention: Homologous B/Yamagata/88 wild-type virus
Number of subjects: 14
Study: 3567042

Group type: EXPERIMENTAL
Intervention: Intravenous midazolam (15 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Oral midazolam (15 mg)
Number of subjects: 8
Study: 30341261

Group type: EXPERIMENTAL
Intervention: Ondansetron with dexamethasone
Number of subjects: 30

Group type: COMPARATOR
Intervention: Clonidine with dexamethasone
Number of subjects: 30
Study: 27558788

Group type: EXPERIMENTAL
Intervention: Active CBM (Cognitive Bias Modification)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Active tDCS (transcranial direct current stimulation)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control CBM
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Active tDCS and CBM
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: CBM and tDCS
Number of subjects: 78
Study: 24431427

Group type: EXPERIMENTAL
Intervention: Multisensory temporal tasks with simple and complex stimuli
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Perceptual binding of audiovisual speech
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 22008247

Group type: EXPERIMENTAL
Intervention: Daily anticholinergic therapy plus a single intra‐detrusor injection of saline
Number of subjects: 242

Group type: COMPARATOR
Intervention: Single intra‐detrusor injection of 100 U of botulinum toxin A plus daily oral placebo tablets
Number of subjects: 242
Study: 21053477

Group type: EXPERIMENTAL
Intervention: Omeprazole plus bicarbonate powder (OBA: omeprazole 20 mg, sodium bicarbonate 1680 mg, alginic acid 250 mg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Omeprazole capsules (OMZ: omeprazole 20 mg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Omeprazole capsules (OMZ)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Omeprazole plus bicarbonate powder (OBA)
Number of subjects: 48
Study: 18672295

Group type: EXPERIMENTAL
Intervention: Laser treatment
Number of subjects: 1052

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 1052
Study: 15734783

Group type: EXPERIMENTAL
Intervention: Activated recombinant coagulation factor VII (rFVIIa) 90 microg kg(‐1)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Activated recombinant coagulation factor VII (rFVIIa)
Number of subjects: 48
Study: 12627298

Group type: EXPERIMENTAL
Intervention: Plyometric training (6 weeks)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (normal training)
Number of subjects: 17
Study: 10100180

Group type: EXPERIMENTAL
Intervention: Estroprogestin replacement therapy (ERT)
Number of subjects: 40
Study: 8914118

Group type: EXPERIMENTAL
Intervention: Cyanocobalamin (CB12) 3 mg for 14 days
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Methylcobalamin (MB12) 3 mg for 14 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (pre-treatment observation for 9 days)
Number of subjects: 20
Study: 1860150

Group type: EXPERIMENTAL
Intervention: Edmonston-Zagreb (E-Z) vaccine, 3.9 log 50 infectious units
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Schwarz vaccine, 3.28 log 50 infectious units
Number of subjects: 124
Study: 7173186

Group type: EXPERIMENTAL
Intervention: 500 mg amoxicillin
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 125 mg potassium clavulanate
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 625 mg amoxicillin and potassium clavulanate combination (augmentin)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (administration alone)
Number of subjects: 10
Study: 31812956

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure management (target SBP 130-140 mm Hg) with standard-dose alteplase (0.9 mg/kg)
Number of subjects: 925

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure management (target SBP 130-140 mm Hg) with low-dose alteplase (0.6 mg/kg)
Number of subjects: 925

Group type: COMPARATOR
Intervention: Guideline-recommended blood pressure management (target SBP <180 mm Hg) with standard-dose alteplase (0.9 mg/kg)
Number of subjects: 925

Group type: COMPARATOR
Intervention: Guideline-recommended blood pressure management (target SBP <180 mm Hg) with low-dose alteplase (0.6 mg/kg)
Number of subjects: 925
Study: 30015580

Group type: EXPERIMENTAL
Intervention: Dehydration (DEH)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Euhydration (EUH)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 40
Study: 26445898

Group type: EXPERIMENTAL
Intervention: MPACT group (functional resistance and walking program)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: MPACT group
Number of subjects: 20
Study: 24439644

Group type: EXPERIMENTAL
Intervention: Foot reflexology massage on the left foot for 20 minutes a day for 4 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: Gentle foot rub with oil for one minute
Number of subjects: 80
Study: 21523893

Group type: EXPERIMENTAL
Intervention: Biodegradable polymer-based sirolimus-eluting stent with six months of dual antiplatelet therapy (clopidogrel and aspirin)
Number of subjects: 2077

Group type: COMPARATOR
Intervention: Prolonged clopidogrel therapy (>6 months)
Number of subjects: 2077
Study: 19105915

Group type: EXPERIMENTAL
Intervention: Intensified treatment
Number of subjects: 498

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 498
Study: 17335116

Group type: EXPERIMENTAL
Intervention: Spirulina (3 g/day)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study: 15489477

Group type: EXPERIMENTAL
Intervention: Periocular injections of triamcinolone acetate (20 mg, 40 mg/ml)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 50
Study: 11137804

Group type: EXPERIMENTAL
Intervention: Retroperitoneal approach
Number of subjects: 120

Group type: COMPARATOR
Intervention: Transperitoneal approach
Number of subjects: 120
Study: 9775244

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 10
Study: 7830631

Group type: EXPERIMENTAL
Intervention: Psyllium cereal (50 g containing 12 g soluble fibre)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Wheat cereal (60 g containing 2 g soluble fibre)
Number of subjects: 81
Study: 3139804

Group type: EXPERIMENTAL
Intervention: Programmed ovulation induction with clomiphene citrate and hMG
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Programmed ovulation induction with FSH and hMG
Number of subjects: 42

Group type: COMPARATOR
Intervention: Nonprogrammed group (control)
Number of subjects: 42
Study: 29654119

Group type: EXPERIMENTAL
Intervention: Resolute Integrity zotarolimus‐eluting stent
Number of subjects: 60

Group type: COMPARATOR
Intervention: BioMatrix NeoFlex Biolimus A9‐eluting stent
Number of subjects: 60
Study: 26453641

Group type: EXPERIMENTAL
Intervention: ONO-9054 morning dosing (1 drop to each eye at 07:00)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: ONO-9054 evening dosing (1 drop to each eye at 19:00)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Vehicle (placebo) evening dosing
Number of subjects: 12
Study: 25470888

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (group M, n=20)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Lidocaine (group L)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline (control group C)
Number of subjects: 60
Study: 22092389

Group type: EXPERIMENTAL
Intervention: 2.5 mL of 2% lidocaine (low volume-high concentration)
Number of subjects: 120

Group type: COMPARATOR
Intervention: 5 mL of 1% lidocaine (high volume-low concentration)
Number of subjects: 120
Study: 20471807

Group type: EXPERIMENTAL
Intervention: Meat-Githeri
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: Milk-Githeri
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: Energy-Githeri
Number of subjects: 554

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 554
Study: 18950300

Group type: EXPERIMENTAL
Intervention: Insulin-treated diabetic patients
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: Noninsulin-treated diabetic patients
Number of subjects: 447

Group type: COMPARATOR
Intervention: Nondiabetic patients
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: Diabetic patients (overall)
Number of subjects: 447
Study: 16809351

Group type: EXPERIMENTAL
Intervention: BioBran MGN-3 (2 g three times per day for 8 weeks)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo equivalent
Number of subjects: 71
Study: 12809196

Group type: EXPERIMENTAL
Intervention: Cognitive intervention (n = 34)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Physical exercise (n = 30)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group (n = 29)
Number of subjects: 93
Study: 11322158

Group type: EXPERIMENTAL
Intervention: Low-pass filtering with increasing cutoff
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inter-digit interval
Number of subjects: 0
Study: 8880241

Group type: EXPERIMENTAL
Intervention: Continuous arteriovenous hemofiltration (CAVH)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Intermittent hemodialysis (HD)
Number of subjects: 27
Study: 1996592

Group type: EXPERIMENTAL
Intervention: Fludarabine 30 mg/m2 over 30 minutes daily for 5 days every 4 weeks
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Fludarabine 30 mg/m2 over 30 minutes daily for 5 days every 4 weeks with prednisone
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Fludarabine therapy
Number of subjects: 17
Study: 6093520

Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 91

Group type: COMPARATOR
Intervention: Amoxicillin
Number of subjects: 91
Study: 31246609

Group type: EXPERIMENTAL
Intervention: Statin users (5,354 patients)
Number of subjects: 24528
Study: 30381023

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 26653101

Group type: EXPERIMENTAL
Intervention: DASH (Dietary Approaches to Stop Hypertension) intervention
Number of subjects: 90
Study: 23836730

Group type: EXPERIMENTAL
Intervention: Hypercaloric feeding (30% calorie excess)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Isocaloric feeding
Number of subjects: 8
Study: 22160489

Group type: EXPERIMENTAL
Intervention: ∆(9)‐tetrahydrocannabinol (THC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21148220

Group type: EXPERIMENTAL
Intervention: 20.9 lb (9.5 kg) carbon frame bicycle
Number of subjects: 1

Group type: COMPARATOR
Intervention: 29.75 lb (13.5 kg) steel frame bicycle
Number of subjects: 1
Study: 18055725

Group type: EXPERIMENTAL
Intervention: Mifepristone 200 mg
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 16294079

Group type: EXPERIMENTAL
Intervention: Nebulized morphine every 4 hours
Number of subjects: 44

Group type: COMPARATOR
Intervention: Patient-controlled analgesia (PCA) morphine
Number of subjects: 44
Study: 11786571

Group type: EXPERIMENTAL
Intervention: Five-drug induction regimen (standard or intensive timing)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Allogeneic bone marrow transplantation (BMT)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Aggressive nonmyeloablative chemotherapy
Number of subjects: 90

Group type: COMPARATOR
Intervention: De novo AML
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 90
Study: 9820446

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 412

Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 412
Study: 7633746

Group type: EXPERIMENTAL
Intervention: Maneuver B: rapid exhalation from FRC to RV and long apnea at RV
Number of subjects: 9

Group type: COMPARATOR
Intervention: Maneuver A: rapid exhalation from FRC to RV
Number of subjects: 9

Group type: COMPARATOR
Intervention: Maneuver C: rapid exhalation from FRC to RV and short apnea at RV
Number of subjects: 9

Group type: COMPARATOR
Intervention: Maneuver D: slow exhalation at a constant speed from FRC to RV
Number of subjects: 9

Group type: COMPARATOR
Intervention: Maneuver E: curvilinear exhalation from FRC to RV
Number of subjects: 9
Study: 2575981

Group type: EXPERIMENTAL
Intervention: epanolol 200mg daily
Number of subjects: 500

Group type: COMPARATOR
Intervention: metoprolol 100mg twice a day
Number of subjects: 500

Group type: COMPARATOR
Intervention: nifedipine retard 20mg twice a day
Number of subjects: 500
Study: 321088

Group type: EXPERIMENTAL
Intervention: Cholestyramine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29329046

Group type: EXPERIMENTAL
Intervention: Social contact intervention
Number of subjects: 219

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 219
Study: 27398897

Group type: EXPERIMENTAL
Intervention: Robotic-guided minimally invasive spine surgery (RO)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Fluoroscopic-guided open surgery (FA)
Number of subjects: 30
Study: 25689244

Group type: EXPERIMENTAL
Intervention: Citalopram 20 mg/day
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Fluvoxamine 100 mg/day
Number of subjects: 15

Group type: COMPARATOR
Intervention: Clopidogrel (300 mg loading dose, then 75 mg/day)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Fluvoxamine with Clopidogrel
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Citalopram with Clopidogrel
Number of subjects: 15
Study: 23485342

Group type: EXPERIMENTAL
Intervention: Clothing made of cellulose fibers with seaweed enriched with silver ions
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo clothing (control group)
Number of subjects: 19
Study: 20538132

Group type: EXPERIMENTAL
Intervention: Bolus injection of furosemide (mean dose 162 ± 48 mg/24 hours)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Continuous infusion of furosemide (mean dose 162 ± 52 mg/24 hours)
Number of subjects: 41
Study: 18412301

Group type: EXPERIMENTAL
Intervention: Reciprocating procedure device (RPD)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Conventional syringe
Number of subjects: 47
Study: 17009113

Group type: COMPARATOR
Intervention: Fentanyl (2 microg/kg) with midazolam (0.05 mg/kg)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Tramadol (1 mg/kg) with midazolam (0.05 mg/kg)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Tramadol (2 mg/kg) with midazolam (0.05 mg/kg)
Number of subjects: 150
Study: 12699522

Group type: EXPERIMENTAL
Intervention: Initial diabetes training for the emergency team and standardized protocol for prehospital emergency therapy of severe hypoglycaemia (SH)
Number of subjects: 7804

Group type: EXPERIMENTAL
Intervention: Education of insulin-treated patients about their diabetes
Number of subjects: 7804

Group type: EXPERIMENTAL
Intervention: Mandatory additional glucose infusions and hospitalization for sulfonylurea-induced SH
Number of subjects: 7804
Study: 11083314

Group type: EXPERIMENTAL
Intervention: Midazolam (30 microg/kg IV)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 65
Study: 8928243

Group type: EXPERIMENTAL
Intervention: Finasteride 5 mg daily for 24 months
Number of subjects: 707

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 707
Study: 1352012

Group type: EXPERIMENTAL
Intervention: Hypnosis alone
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Anger
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Excitement
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Happiness
Number of subjects: 18
Study: 6430439

Group type: EXPERIMENTAL
Intervention: Scintiphotography with gallium‐67 (67Ga)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Determination of renal beta 2 microglobulin excretion
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Immunofluorescence of antibody coated bacteria
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Scintiphotography with 67Ga and determination of renal beta 2 microglobulin excretion
Number of subjects: 34

Group type: COMPARATOR
Intervention: Excretion of beta 2 microglobulin and uptake of 67Ga in patients with lower urinary tract infections
Number of subjects: 34
Study: 31775414

Group type: EXPERIMENTAL
Intervention: Radiofrequency thermocoagulation through foramen rotundum (FR)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Radiofrequency thermocoagulation through foramen ovale (FO)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Gasserian ganglion ablation through the Hartel approach (FO)
Number of subjects: 80
Study: 31099333

Group type: EXPERIMENTAL
Intervention: 250 mg/day magnesium oxide
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 27067676

Group type: EXPERIMENTAL
Intervention: Eight weekly one hour meditation‐focused mind/body classes teaching concentration and insight meditation skills along with mind/body exercises.
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Eight weekly one hour meditation‐focused mind/body classes.
Number of subjects: 41
Study: 24436297

Group type: EXPERIMENTAL
Intervention: Midodrine (10 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (AB individuals)
Number of subjects: 20